The Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator<unk>  is a global nonprofit partnership focused on supporting antibacterial research. Its mission is to strengthen the pipeline of therapeutics, diagnostics and preventatives to diagnose and treat life-threatening bacterial infections.<unk>  was launched in summer of 2016 at the Boston University School of Law, where<unk>  Executive Director Professor Kevin Outterson teaches health law, corporate law, and co-directs the Health Law Program. In its first five years, from 2016-2021,<unk>  awarded $361 million to 92 projects. In addition to awarding non-dilutive funding,<unk>  partners with a Global Accelerator Network (GAN) of experts who offer product developers advice on a range of issues, including drug development, business strategy, policy and regulatory affairs.
CARB-X
CURB-65
BGR-34
ONCOS-102
COVAX-19
C-KAD
MCN
GL-ONC1